These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Ammoniacal silver staining of lymph node cells. II. Reactive follicular hyperplasia and its relationship with Hodgkin's disease. Rengifo E; Quintero S; Marinello Z Neoplasma; 1985; 32(6):741-4. PubMed ID: 2418374 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease. Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329 [TBL] [Abstract][Full Text] [Related]
8. The ultrastructural identification of tissue basophils and mast cells in Hodgkin's disease. Parmley RT; Spicer SS; Wright NJ Lab Invest; 1975 Apr; 32(4):469-75. PubMed ID: 1127869 [TBL] [Abstract][Full Text] [Related]
9. In-vitro sensitivity of Hodgkin's disease to hydrogen peroxide toxicity. Correlation with peroxidase activity. Samoszuk MK; Rietveld C; Gidanian F; Petersen A Cancer; 1989 Jun; 63(11):2111-4. PubMed ID: 2541883 [TBL] [Abstract][Full Text] [Related]
10. Histological Studies in Hodgkin's disease. Elsner B Beitr Pathol; 1975 Nov; 156(2):101-8. PubMed ID: 1212162 [TBL] [Abstract][Full Text] [Related]
11. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Burns BF; Colby TV; Dorfman RF Am J Surg Pathol; 1984 Apr; 8(4):253-61. PubMed ID: 6369997 [TBL] [Abstract][Full Text] [Related]
12. Cytological basis of histological typing of diffuse Hodgkin's disease. Demonstration of an implied misnomer in the terminology of the Rye classification. Livesey AE; Sutherland FI; Brown RA; Beck JS; Macgillivray JB; Slidders W J Clin Pathol; 1978 Jun; 31(6):551-9. PubMed ID: 670411 [TBL] [Abstract][Full Text] [Related]
13. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease. Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684 [TBL] [Abstract][Full Text] [Related]
14. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome. Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595 [TBL] [Abstract][Full Text] [Related]
15. [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma]. Rygoł B; Kyrcz-Krzemień S; Pajiak J; Konicki P; Kowai E; Gasińska T Pol Arch Med Wewn; 2007; 117(1-2):27-32. PubMed ID: 17642203 [TBL] [Abstract][Full Text] [Related]
16. A quantitative study of alpha-naphthyl acetate esterase-positive cells in Hodgkin's disease. Crocker J; Jones EL; Curran RC J Clin Pathol; 1982 Dec; 35(12):1301-6. PubMed ID: 6757271 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte predominant Hodgkin's disease of nodular subtype combined with pulmonary lymphoid infiltration and hypogammaglobulinaemia. Li G; Hansmann ML Virchows Arch A Pathol Anat Histopathol; 1989; 415(5):481-7. PubMed ID: 2508307 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localisation of factor VIII-related antigen in Hodgkin's disease. Crocker J; Smith PJ J Clin Pathol; 1984 Jan; 37(1):37-44. PubMed ID: 6423698 [TBL] [Abstract][Full Text] [Related]